Approving Sun Pharma’s proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the Subject Expert Committee (SEC) functional under the...
Continue ReadingCipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered company started its investment journey...
Continue ReadingDrugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization (CDSCO), in its minutes for the meeting held...
Continue ReadingHetero, a city-based leading pharmaceutical company announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of...
Continue ReadingGenomics India 2023, the 2- day extravaganza is here! A perfect amalgam of science and ideas that it is, our conference will discuss applications of...
Continue ReadingBiocon Limited announced the initiation of the clinical study of Itolizumab, a monoclonal antibody in patients with Ulcerative Colitis (UC) in India, in collaboration with...
Continue ReadingHyderabad-based-Biological E. Limited (BE) announced that it has received marketing approval from the Drugs Controller General of India (DCGI) for its Pneumococcal Conjugate vaccine (PCV14)...
Continue ReadingDr Jagadeeshs Gouda, a renowned seed industry researcher has joined the management team of Yaganti Agrotech Pvt Ltd ( BHARATI SEEDS ). Coming with more...
Continue ReadingGenomics India Conference is back after a three year gap! GIC, in 2023, is going to be bigger and better! We take immense pleasure in...
Continue Reading